The study will measure insulin pen use and continuous blood glucose response automatically, around the clock for 125 participants, according to a Common Sensing document describing the trial.

Designed to replace the caps on the most common insulin pens, a built-in timer on an LCD display automatically counts up when the cap is attached, and instantly resets when it’s removed.

Bigfoot Unity caps can be used by anyone ages 12 and up, and also work with all major insulin pens—both rapid and long-acting—from Eli Lilly and Company, Novo Nordisk, and Sanofi.

The smart pen cap for rapid-acting insulin allows the user to scan the FreeStyle Libre 2 sensor, displaying the user’s current glucose value, trend arrow and any recommended correction dose.

The startup received 510(k) clearance for its “smart” insulin pen cap, which pulls in data from users’ connected glucose monitor to help them calculate the right dose. Health systems have ...

The Bigfoot Unity System is comprised of a cap that attaches to insulin pens to provide CGM readings and dose recommendations for people with type 1 or type 2 diabetes who take multiple daily ...

Common Sensing, a Cambridge-based company developing a smart connected insulin pen cap, announced that it will test its device in a clinical trial in collaboration with Joslin Diabetes Center, Sanofi, ...

Insulin price caps are ... with Providence Mission Hospital in Orange County said 90% of the insulin he prescribes is delivered through preloaded pens. "They are typically younger patients ...

The policy, tucked into Democrats’ sprawling economic package, went into effect Jan. 1 for those using insulin pens through Medicare’s prescription drug benefit and will begin July 1 for those ...

GREENSBORO, N.C. — The headline reads, “Lilly cuts insulin prices by 70% and caps patient insulin out-of-pocket costs at $35 per month”. It's a great headline for millions of people. There ...

Patients Pending, a London-based health startup founded by one of the co-creators of Skype and his brother, has announced that it will follow up its Timesulin insulin pen cap with a ...